Nov 14, 2017

Concerning Today's Certain Media Report

Tokyo, November 14, 2017 -- There was a media report by Nikkei today that Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) has decided to divest its off-patent drug business to a third party. However, this report is not based on any announcement made by Chugai or information provided by Chugai.

It is our policy to fairly and timely disclose material information including information which may impact the share price. Chugai has and will maintain this policy.

Contact:

  • For Media
  • Chugai Pharmaceutical Co., Ltd.
  • Media Relations Group, Corporate Communications Dept.,
  • Koki Harada
  • Tel: +81-3-3273-0881
  • E-mail: pr@chugai-pharm.co.jp
  • For Investors
  • Chugai Pharmaceutical Co., Ltd.
  • Investor Relations Group, Corporate Communications Dept.,
  • Toshiya Sasai
  • Tel: +81-3-3273-0554
  • E-mail: ir@chugai-pharm.co.jp
  • Like
  • Tweet
  • LINE it!
  • E-mail
Back to top